ATE254481T1 - Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie - Google Patents

Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie

Info

Publication number
ATE254481T1
ATE254481T1 AT96400493T AT96400493T ATE254481T1 AT E254481 T1 ATE254481 T1 AT E254481T1 AT 96400493 T AT96400493 T AT 96400493T AT 96400493 T AT96400493 T AT 96400493T AT E254481 T1 ATE254481 T1 AT E254481T1
Authority
AT
Austria
Prior art keywords
chitosan complex
cancer
radioactive
radiation therapy
radioactive chitosan
Prior art date
Application number
AT96400493T
Other languages
English (en)
Inventor
Kyoung-Bae Park
Young-Mi Kim
Jae-Rock Kim
Original Assignee
Korea Atomic Energy Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Atomic Energy Res filed Critical Korea Atomic Energy Res
Application granted granted Critical
Publication of ATE254481T1 publication Critical patent/ATE254481T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96400493T 1995-03-10 1996-03-08 Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie ATE254481T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19950004872 1995-03-10
KR1019960005038A KR100190957B1 (ko) 1995-03-10 1996-02-28 방사성 키토산 착물, 방사성 키토산 응집입자 및 방사성키토산 착물 제조용 키트, 그리고 그들의 제조방법 및 용도

Publications (1)

Publication Number Publication Date
ATE254481T1 true ATE254481T1 (de) 2003-12-15

Family

ID=26630908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96400493T ATE254481T1 (de) 1995-03-10 1996-03-08 Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie

Country Status (8)

Country Link
EP (1) EP0730871B1 (de)
JP (1) JP3048915B2 (de)
KR (1) KR100190957B1 (de)
CN (3) CN1131072C (de)
AT (1) ATE254481T1 (de)
DE (1) DE69630727T2 (de)
DK (1) DK0730871T3 (de)
PT (1) PT730871E (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
KR100530276B1 (ko) * 1998-10-12 2006-02-28 서울대학교병원 입자성 방사성핵종 포합 중합체, 그 제조방법 및 그 제조용킷트
US6660247B1 (en) 2000-06-23 2003-12-09 Battelle Memorial Institute Multiple stimulus reversible hydrogels
US20040197264A1 (en) * 2003-04-04 2004-10-07 Alexander Schwarz Microspheres comprising therapeutic and diagnostic radioactive isotopes
KR100700418B1 (ko) * 2003-09-08 2007-03-29 한국원자력연구소 방사성물질-키토산 복합체를 함유하는 전립선암 치료용조성물 및 조성물 제조용 키트
KR101080056B1 (ko) * 2004-12-01 2011-11-04 한국원자력연구원 체내 주사시 겔화 안정성이 개선된 방사성물질-키토산복합체용액 조성물 및 그 제조 방법
KR100704548B1 (ko) 2005-10-31 2007-04-09 한국과학기술연구원 염증 부위 특이적 고분자 유도체 및 그의 용도
CN100450553C (zh) * 2006-11-16 2009-01-14 沈阳 可降解放射性海绵及其制造工艺
NL2009688C2 (en) * 2012-10-24 2014-04-29 Nucletron Operations Bv A settable radioactive gel, a method of manufacturing a settable radioactive gel, a device for manufacturing a settable radioactive gel.
US10799587B2 (en) * 2016-05-11 2020-10-13 Huan NIU Ion implantation of neutron capture elements into nanodiamond particles to form composition for neutron capture therapy usage
CN107811752A (zh) * 2017-09-21 2018-03-20 温州医科大学 一种生物相容性青光眼房水引流管及其制备方法
KR101977185B1 (ko) * 2017-11-07 2019-05-10 한국원자력연구원 난치성 질환 치료 및 진단을 위한 생체 내 발생기 기능을 갖는 마이크로입자
US20220265871A1 (en) * 2019-06-14 2022-08-25 Advanced Accelerator Applications Method of Treating Cancer by Intratumoral Deposition of Radioactive Microparticles
MX2023003016A (es) 2020-09-22 2023-04-10 Swimc Llc Composiciones de recubrimiento que contienen quitosana.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01211529A (ja) * 1988-02-19 1989-08-24 Tomoji Tanaka キチン、キトサン化合物を基材とした薬剤
US5061476A (en) * 1989-12-27 1991-10-29 The Dow Chemical Company Radiolabeled colloid compositions and method for preparing same
US5336415A (en) 1993-02-10 1994-08-09 Vanson L.P. Removing polyvalent metals from aqueous waste streams with chitosan and halogenating agents
JP3727074B2 (ja) * 1993-10-26 2005-12-14 日本メジフィジックス株式会社 局所投与放射線治療剤

Also Published As

Publication number Publication date
CN1343521A (zh) 2002-04-10
CN100528242C (zh) 2009-08-19
CN1139116A (zh) 1997-01-01
PT730871E (pt) 2004-07-30
CN1196498C (zh) 2005-04-13
JPH08311105A (ja) 1996-11-26
CN1131072C (zh) 2003-12-17
JP3048915B2 (ja) 2000-06-05
KR100190957B1 (ko) 1999-06-15
CN1343522A (zh) 2002-04-10
DE69630727T2 (de) 2004-09-30
KR960033472A (ko) 1996-10-22
DK0730871T3 (da) 2004-07-26
DE69630727D1 (de) 2003-12-24
EP0730871B1 (de) 2003-11-19
EP0730871A1 (de) 1996-09-11

Similar Documents

Publication Publication Date Title
ATE254481T1 (de) Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie
BR9915080A (pt) Fonte radioativa para uso em braquiterapia, métodos para a preparação de uma fonte radioativa e para tratamento de uma condição que responde à terapia de radiação, e, composição
US5484778C1 (en) Phthalocynine photosensitizers for photodynamic therapy and methods for their use
MXPA02011325A (es) Fuentes ranuradas para braquiterapia.
ID22689A (id) Metode untuk mengaktifkan sel-sel yang menunjukan-sifat antigen manusia, sel-sel teraktifkan yang menunjukan sifat antigen manusia, dan penggunaannya
BR9107074A (pt) Imunorreagente radioativo de marcacao,composicao e processo de formacao de imagem diagnostica,composicao terapeutica,processo de tratamentod e silios doentios e composicao da materia
AU3035189A (en) Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents
IL90990A0 (en) Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof
DE60011045D1 (de) Biolgisch abbaubare glaszusammensetzungen und deren verwendung zur herstellung eines medikaments für strahlungstherapie
GB9314623D0 (en) Localization and therapy with agents directed against prostate specific antigen in breast cancer
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
WO1997005904A3 (de) Verwendung von metall-clustern als kontrastmittel oder strahlentherapeutikum
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
NO953349D0 (no) Kombinasjonsterapi av human cancer med cisplatin/tamoxifen
RU94035764A (ru) Способ лечения онкологического заболевания
CA2172607A1 (en) Phorbine Derivatives and Their Use in the Diagnosis and Therapy of Cancer
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents
KR960033481A (ko) 피부질환 치료용 방사성팻취와 그 제조방법
SU1826193A1 (ru) Способ получения церулоплазмина
EP0415198A3 (en) Ketophosphamidyl glycosides, process for their preparation and their use as pharmaceutical agents
IT8322370A0 (it) Applicazione terapeutica delmazindolo nella malattia di parkinson.
PT678027E (pt) Agentes anti-ateromatosos
HU904856D0 (en) Process for the production of immunostimulating preparations and application therapy for aids-stop medical treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEWE Authorization for restitution
UEP Publication of translation of european patent specification

Ref document number: 0730871

Country of ref document: EP